Cloverleaf Bio

Seed
cloverleafbio.com Biotech & Healthcare New Haven, United States
Total Funding $33M
Latest Round $33M Seed
Last Announced Sep 8, 2026
Investors 7 Backers
Decision Makers 3 Verified

About Cloverleaf Bio

Cloverleaf Bio develops an RNA therapeutic platform for oncology.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters New Haven, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website cloverleafbio.com
Domain Registered Date Jan 10, 2023

Social & Network Presence

X / Twitter Profile @cloverleafbio (25 followers) Created on Jan 2023
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $33,000,000 · Seed

    hartfordbusiness.com

  2. Milestone

    X account created (@cloverleafbio)

    25 followers

  3. Milestone

    Website domain registered

    cloverleafbio.com

Investors & Backers

7
4BIO Capital
AbbVie
Boehringer Ingelheim Venture Fund
BrightEdge - American Cancer Society
Draper Associates
Eli Lilly
Mission BioCapital

Funding History

1 Round
Seed · Sep 8, 2026

Founders & Leadership

3

Austin Draycott

Founder

Work email & phone locked Unlock →

Cole Lewis

Founder

Work email & phone locked Unlock →

Wendy V. Gilbert

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts